LEXARIA BIOSCIENCE CORP. Property, Plant and Equipment, Additions
LEXARIA BIOSCIENCE CORP. (LEXX) reported Property, Plant and Equipment, Additions of $40.82 thousand for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes › and Equipment
us-gaap:PropertyPlantAndEquipmentAdditions · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for the quarter ending 2026-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for the quarter ending 2026-02-28 was $40.82K.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for the quarter ending 2025-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for the quarter ending 2025-08-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for fiscal 2024 was $43.01K, a 27.46% increase from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for fiscal 2023 was $33.75K, a 31.40% decline from fiscal 2022.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for fiscal 2022 was $49.19K.
- LEXARIA BIOSCIENCE CORP. property, plant and equipment, additions for fiscal 2021 was $0.00.
| Period end | Property, Plant and Equipment, Additions 3 month | Property, Plant and Equipment, Additions 6 month | Property, Plant and Equipment, Additions 9 month | Property, Plant and Equipment, Additions 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | $40.82K derived: sum of 2 quarters · filed 2026-07-13 | $40.82K 10-Q · filed 2026-07-13 | $40.82K derived: sum of 4 quarters · filed 2026-07-13 |
| 2026-02-28 | $40.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | $40.82K 10-Q · filed 2026-04-13 | $40.82K derived: sum of 3 quarters · filed 2026-07-13 | $40.82K derived: sum of 4 quarters · filed 2026-07-13 |
| 2025-11-30 | $0.00 10-Q · filed 2026-01-13 | $0.00 derived: sum of 2 quarters · filed 2026-07-13 | $0.00 derived: sum of 3 quarters · filed 2026-07-13 | $0.00 derived: sum of 4 quarters · filed 2026-07-13 |
| 2025-08-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-13 | $0.00 derived: sum of 2 quarters · filed 2026-07-13 | $0.00 derived: sum of 3 quarters · filed 2026-07-13 | $24.65K 10-Q · filed 2026-07-13 |
| 2025-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-07-14 | $0.00 derived: sum of 2 quarters · filed 2025-07-14 | $24.65K 10-Q · filed 2025-07-14 | $67.66K derived: sum of 4 quarters · filed 2025-11-28 |
| 2025-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-04-14 | $24.65K 10-Q · filed 2025-04-14 | $67.66K derived: sum of 3 quarters · filed 2025-11-28 | $67.66K derived: sum of 4 quarters · filed 2025-11-28 |
| 2024-11-30 | $24.65K 10-Q · filed 2025-01-10 | $67.66K derived: sum of 2 quarters · filed 2025-11-28 | $67.66K derived: sum of 3 quarters · filed 2025-11-28 | $67.66K derived: sum of 4 quarters · filed 2025-11-28 |
| 2024-08-31 | $43.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $43.01K derived: sum of 2 quarters · filed 2025-11-28 | $43.01K derived: sum of 3 quarters · filed 2025-11-28 | $43.01K 10-K · filed 2025-11-28 |
| 2024-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $0.00 derived: sum of 2 quarters · filed 2024-07-12 | $0.00 10-Q · filed 2024-07-12 | $0.00 derived: sum of 4 quarters · filed 2024-11-26 |
| 2024-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $0.00 10-Q · filed 2024-04-09 | $0.00 derived: sum of 3 quarters · filed 2024-11-26 | $0.00 derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-11-30 | $0.00 10-Q · filed 2024-01-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-26 | $0.00 derived: sum of 3 quarters · filed 2024-11-26 | $13.25K derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $0.00 derived: sum of 2 quarters · filed 2024-11-26 | $13.25K derived: sum of 3 quarters · filed 2024-11-26 | $33.75K 10-K · filed 2024-11-26 |
| 2023-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $13.25K derived: sum of 2 quarters · filed 2023-07-14 | $33.75K 10-Q · filed 2023-07-14 | $33.75K derived: sum of 4 quarters · filed 2023-11-20 |
| 2023-02-28 | $13.25K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | $33.75K 10-Q · filed 2023-04-14 | $33.75K derived: sum of 3 quarters · filed 2023-11-20 | $40.56K derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-11-30 | $20.50K 10-Q/A · filed 2023-01-18 | $20.50K derived: sum of 2 quarters · filed 2023-11-20 | $27.32K derived: sum of 3 quarters · filed 2023-11-20 | |
| 2022-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $6.82K derived: sum of 2 quarters · filed 2023-11-20 | $49.19K 10-K · filed 2023-11-20 | |
| 2022-05-31 | $6.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $49.19K 10-Q · filed 2022-07-14 | ||
| 2022-02-28 | $42.38K 10-Q · filed 2022-04-11 | |||
| 2021-08-31 | $0.00 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |